{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Baltimore",
      "address_1": "Harborplace Tower",
      "reason_for_recall": "CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.",
      "address_2": "111 S Calvert St Fl 21st",
      "product_quantity": "34,080 boxes (3 wallets per carton, 80 cartons per box)",
      "code_info": "Lot # L800498, exp. date February 2020",
      "center_classification_date": "20200117",
      "distribution_pattern": "Distributed nationwide in the US",
      "state": "MD",
      "product_description": "Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250 mg/0.025 mg, Pack size - 3 x 28's wallets/carton, Rx Only, Distributed by Lupin Pharmaceuticals, Inc, Baltimore MD 21202, Manufactured by: Lupin Limited, Pithampur, (M.P.)- 454775, India. NDC 68180-837-13 (3x28 carton ) NDC 68180-837-11 (28 tablet wallet)",
      "report_date": "20200122",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "recall_number": "D-0790-2020",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "84674",
      "termination_date": "20210603",
      "more_code_info": "",
      "recall_initiation_date": "20200110",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}